May - 2018

top of page

Press Releases, News and Articles

Defytime Announces Telomere Total Solution Program

May 9, 20181 min read

Defytime Announces Telomere Total Solution Program

Health is a state in which all the parts of the body are functioning normally: all organs, including brain, bones and blood vessels are...

81 views

Defytime Announces Initial Coin Offering (ICO) Public Pre-Sale Start

May 9, 20181 min read

Defytime Announces Initial Coin Offering (ICO) Public Pre-Sale Start

We hereby have the pleasure to officially announce our Public ICO Plan, details below. Defytime will host a pre-sale ICO for friends and...

61 views

Featured Posts

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Recent Posts

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Rapidly Aging Cells May Contribute to Shorter Lifespan of Fabry Patients, Study Finds

Shorter Telomeres Increase Risk for MS Disability Progression

Archive

Search By Tags

bottom of page